Drug: CLONAZEPAM. Injury: Product use issue Quarter: 2016Q3
Total Records: 23 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 122562524 | CLONAZEPAM. | Product use issue | JOHNSON AND JOHNSON | 48.00 YR | F | 0 | 20160806 | US |
| 125614111 | CLONAZEPAM. | Product use issue | PAR | 0.00 | 0 | 20160715 | US | |
| 126490771 | CLONAZEPAM. | Product use issue | UNICHEM | 0.00 | M | 105 KG | 20160812 | US |
| 126542071 | CLONAZEPAM. | Product use issue | 62.00 YR | F | 190 LBS | 20160815 | US | |
| 126831962 | CLONAZEPAM. | Product use issue | SANDOZ | 24.00 YR | M | 0 | 20160826 | US |
| 127774651 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | M | 75 KG | 20160924 | US |
| 127774911 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775031 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775041 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 65 KG | 20160924 | US |
| 127775061 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | M | 0 | 20160924 | US |
| 127775081 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775111 | CLONAZEPAM. | Product use issue | TEVA | 64.77 YR | M | 0 | 20160924 | US |
| 127775231 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775241 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775261 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775331 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 49 KG | 20160924 | US |
| 127775361 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 0 | 20160924 | US |
| 127775401 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 82 KG | 20160924 | US |
| 127775431 | CLONAZEPAM. | Product use issue | TEVA | 34.10 YR | M | 65 KG | 20160924 | US |
| 127775521 | CLONAZEPAM. | Product use issue | TEVA | 0.00 | F | 61 KG | 20160924 | US |
Total Records: 23 Number of Pages: 2